Published in Biol Psychiatry on June 05, 2007
Functional atlas of emotional faces processing: a voxel-based meta-analysis of 105 functional magnetic resonance imaging studies. J Psychiatry Neurosci (2009) 4.16
Erythropoietin for infants with hypoxic-ischemic encephalopathy. Curr Opin Pediatr (2010) 1.08
Effects of erythropoietin on emotional processing biases in patients with major depression: an exploratory fMRI study. Psychopharmacology (Berl) (2009) 0.94
Neuroplasticity and the next wave of antidepressant strategies. Front Cell Neurosci (2013) 0.92
Promises and pitfalls in erythopoietin-mediated tissue protection: are nonerythropoietic derivatives a way forward? J Investig Med (2011) 0.92
Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression. Psychopharmacology (Berl) (2011) 0.89
Vascular growth factors in neuropsychiatry. Cell Mol Life Sci (2013) 0.86
Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder. Trials (2010) 0.84
Antidepressant-like effects of erythropoietin: a focus on behavioural and hippocampal processes. PLoS One (2013) 0.83
Erythropoietin modulates neural and cognitive processing of emotional information in biomarker models of antidepressant drug action in depressed patients. Psychopharmacology (Berl) (2010) 0.81
Recombinant human erythropoietin for treating treatment-resistant depression: a double-blind, randomized, placebo-controlled phase 2 trial. Neuropsychopharmacology (2013) 0.81
Erythropoietin Pathway: A Potential Target for the Treatment of Depression. Int J Mol Sci (2016) 0.79
A neurocognitive model for understanding treatment action in depression. Philos Trans R Soc Lond B Biol Sci (2015) 0.78
Perioperative erythropoietin protects the CNS against ischemic lesions in patients after open heart surgery. Wien Klin Wochenschr (2016) 0.75
Effect of acute antidepressant administration on negative affective bias in depressed patients. Am J Psychiatry (2009) 3.04
Increased neural processing of rewarding and aversive food stimuli in recovered anorexia nervosa. Biol Psychiatry (2011) 2.06
Neural processing of reward and punishment in young people at increased familial risk of depression. Biol Psychiatry (2012) 1.87
Low-dose tryptophan depletion in recovered depressed patients induces changes in cognitive processing without depressive symptoms. Biol Psychiatry (2005) 1.73
Lateral prefrontal cortex mediates the cognitive modification of attentional bias. Biol Psychiatry (2009) 1.70
Diminished neural processing of aversive and rewarding stimuli during selective serotonin reuptake inhibitor treatment. Biol Psychiatry (2009) 1.63
Changes in automatic threat processing precede and predict clinical changes with exposure-based cognitive-behavior therapy for panic disorder. Biol Psychiatry (2013) 1.58
Effect of a single dose of citalopram on amygdala response to emotional faces. Br J Psychiatry (2009) 1.49
Increased waking salivary cortisol levels in young people at familial risk of depression. Am J Psychiatry (2007) 1.47
Using attentional bias modification as a cognitive vaccine against depression. Biol Psychiatry (2012) 1.44
Neural representation of reward in recovered depressed patients. Psychopharmacology (Berl) (2009) 1.43
The modification of attentional bias to emotional information: A review of the techniques, mechanisms, and relevance to emotional disorders. Cogn Affect Behav Neurosci (2010) 1.40
Oxytocin enhances processing of positive versus negative emotional information in healthy male volunteers. J Psychopharmacol (2008) 1.34
Cognitive Bias Modification Using Mental Imagery for Depression: Developing a Novel Computerized Intervention to Change Negative Thinking Styles. Eur J Pers (2011) 1.30
Normalization of enhanced fear recognition by acute SSRI treatment in subjects with a previous history of depression. Am J Psychiatry (2004) 1.20
Risk for depression and neural responses to fearful facial expressions of emotion. Br J Psychiatry (2009) 1.17
Erythropoietin enhances hippocampal response during memory retrieval in humans. J Neurosci (2007) 1.11
Highly neurotic never-depressed students have negative biases in information processing. Psychol Med (2007) 1.11
Enhanced early morning salivary cortisol in neuroticism. Am J Psychiatry (2005) 1.10
Short-term antidepressant treatment and facial processing. Functional magnetic resonance imaging study. Br J Psychiatry (2007) 1.10
Short-term antidepressant treatment modulates amygdala response to happy faces. Psychopharmacology (Berl) (2009) 1.09
Short-term serotonergic but not noradrenergic antidepressant administration reduces attentional vigilance to threat in healthy volunteers. Int J Neuropsychopharmacol (2008) 1.04
Acute administration of the cannabinoid CB1 antagonist rimonabant impairs positive affective memory in healthy volunteers. Psychopharmacology (Berl) (2009) 0.98
Differential effects of erythropoietin on neural and cognitive measures of executive function 3 and 7 days post-administration. Exp Brain Res (2007) 0.97
Tryptophan supplementation induces a positive bias in the processing of emotional material in healthy female volunteers. Psychopharmacology (Berl) (2006) 0.97
Sex differences in the effect of acute tryptophan depletion on declarative episodic memory: a pooled analysis of nine studies. Neurosci Biobehav Rev (2007) 0.96
Reduced neural response to reward following 7 days treatment with the cannabinoid CB1 antagonist rimonabant in healthy volunteers. Int J Neuropsychopharmacol (2010) 0.96
The role of the anterior cingulate cortex in the counting Stroop task. Exp Brain Res (2003) 0.96
Affective modulation of anterior cingulate cortex in young people at increased familial risk of depression. Br J Psychiatry (2008) 0.95
The role of serotonin in nonnormative risky choice: the effects of tryptophan supplements on the "reflection effect" in healthy adult volunteers. J Cogn Neurosci (2009) 0.95
Effects of erythropoietin on emotional processing biases in patients with major depression: an exploratory fMRI study. Psychopharmacology (Berl) (2009) 0.94
Frontolimbic responses to emotional faces in young people at familial risk of depression. J Affect Disord (2010) 0.94
Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers. Psychopharmacology (Berl) (2014) 0.93
Emotional bias and waking salivary cortisol in relatives of patients with major depression. Psychol Med (2006) 0.91
A dose-finding study on the effects of branch chain amino acids on surrogate markers of brain dopamine function. Psychopharmacology (Berl) (2002) 0.91
A single dose of mirtazapine modulates neural responses to emotional faces in healthy people. Psychopharmacology (Berl) (2010) 0.90
Erythropoietin improves mood and modulates the cognitive and neural processing of emotion 3 days post administration. Neuropsychopharmacology (2007) 0.89
Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression. Psychopharmacology (Berl) (2011) 0.89
The common adolescent bipolar phenotype shows positive biases in emotional processing. Bipolar Disord (2010) 0.89
Effects of acute tyrosine depletion on subjective craving and selective processing of smoking-related cues in abstinent cigarette smokers. J Psychopharmacol (2007) 0.88
Single dose antidepressant administration modulates the neural processing of self-referent personality trait words. Neuroimage (2007) 0.87
Using an experimental medicine model to explore combination effects of pharmacological and cognitive interventions for depression and anxiety. Neuropsychopharmacology (2011) 0.87
Effects of 7 days of treatment with the cannabinoid type 1 receptor antagonist, rimonabant, on emotional processing. J Psychopharmacol (2011) 0.87
Risk for depression is associated with neural biases in emotional categorisation. Neuropsychologia (2008) 0.86
Opposing neural effects of naltrexone on food reward and aversion: implications for the treatment of obesity. Psychopharmacology (Berl) (2014) 0.85
A functional magnetic resonance imaging study of verbal working memory in young people at increased familial risk of depression. Biol Psychiatry (2009) 0.85
Blockade of sensitisation-induced facilitation of appetitive conditioning by post-session intra-amygdala nafadotride. Behav Brain Res (2002) 0.85
Effects of short-term varenicline administration on emotional and cognitive processing in healthy, non-smoking adults: a randomized, double-blind, study. Neuropsychopharmacology (2012) 0.84
NK1 receptor antagonism and the neural processing of emotional information in healthy volunteers. Int J Neuropsychopharmacol (2009) 0.84
Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder. Trials (2010) 0.84
Short-term NK1 receptor antagonism and emotional processing in healthy volunteers. Psychopharmacology (Berl) (2010) 0.83
Impaired emotional categorisation in young people at increased familial risk of depression. Neuropsychologia (2007) 0.83
Lack of effect of tyrosine depletion on mood in recovered depressed women. Neuropsychopharmacology (2005) 0.82
The D2 antagonist sulpiride modulates the neural processing of both rewarding and aversive stimuli in healthy volunteers. Psychopharmacology (Berl) (2011) 0.81
Erythropoietin modulates neural and cognitive processing of emotional information in biomarker models of antidepressant drug action in depressed patients. Psychopharmacology (Berl) (2010) 0.81
Neural responses to emotional faces in women recovered from anorexia nervosa. Psychiatry Res (2012) 0.81
Effects of emotion recognition training on mood among individuals with high levels of depressive symptoms: study protocol for a randomised controlled trial. Trials (2013) 0.80
Expectancy and surprise predict neural and behavioral measures of attention to threatening stimuli. Neuroimage (2011) 0.79
Bilateral generic working memory circuit requires left-lateralized addition for verbal processing. Cereb Cortex (2007) 0.79
Effect of branch chain amino acids supplemented with tryptophan on tyrosine availability and plasma prolactin. Psychopharmacology (Berl) (2001) 0.79
Early markers of cognitive enhancement: developing an implicit measure of cognitive performance. Psychopharmacology (Berl) (2013) 0.79
Low-dose tryptophan depletion in recovered depressed women induces impairments in autobiographical memory specificity. Psychopharmacology (Berl) (2009) 0.79
Acute antidepressant drug administration and autobiographical memory recall: a functional magnetic resonance imaging study. Exp Clin Psychopharmacol (2012) 0.78
Isolation rearing-induced facilitation of Pavlovian learning: abolition by postsession intra-amygdala nafadotride. Physiol Behav (2002) 0.77
Effects of seven-day diazepam administration on resting-state functional connectivity in healthy volunteers: a randomized, double-blind study. Psychopharmacology (Berl) (2014) 0.76
Effects of pramipexole on the processing of rewarding and aversive taste stimuli. Psychopharmacology (Berl) (2013) 0.76
Cognitive vulnerability and implicit emotional processing: imbalance in frontolimbic brain areas? Cogn Affect Behav Neurosci (2015) 0.76
A Selective Nociceptin Receptor Antagonist to Treat Depression: Evidence from Preclinical and Clinical Studies. Neuropsychopharmacology (2016) 0.76
Effects of alpha-lactalbumin on emotional processing in healthy women. J Psychopharmacol (2007) 0.76
Have no fear: the neural basis of anxiolytic drug action in generalized social phobia. Biol Psychiatry (2013) 0.75
Effects of short-term varenicline administration on cortisol in healthy, non-smoking adults: a randomized, double-blind, study. Psychopharmacology (Berl) (2013) 0.75
Short-term quetiapine treatment alters the use of reinforcement signals during risky decision-making and promotes the choice of negative expected values in healthy adult males. J Neurosci (2013) 0.75